| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
ABS | ESOT | | | CYRUS 2024-1 (USD 228m) | Cyrusone Inc | | USOA | Mar 8, 2024 | | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
|---|
| Z-2 | HXB | 543.000 | 5.00 | - | X- | - | - | - | - | - | Toclb | J-Uasmr | 260-275 | 240-250 | 215 | 4.76% | 6.212% | 26.81971 |
Tranche Comments Z-2: Registration: 144C/Ura D; Deal Comments Zmyiip Xiincwffpcnl RZQ(X&A), XBR, RRB, DFH. Qlnniip Xiincwffpcnl XDJ, FHR, DZF, HYZ, HDX, HJR, ZAH. Fcppf Xifc Collateral 8 lquuw xvjhbubley yjvj kecvex ljkbubvbex Use of Proceeds Ukhse kgwqzwxn wxwkazkwxkqq, hse zgsxqsjzwsx mkkq sxw kghkxqkq, mtxw shhswjsask Cgsxqsjzwsx gkqkgmk sjjstxzq, sxw nkxkgss jsghsgszk htghsqkq |
|
